Geron | GERN - Operating Profit

Stock Price
1.95
Daily Change
0.18 10.17%
Monthly
42.34%
Yearly
-17.72%
Q1 Forecast
1.82

Geron reported $-13.89M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
Amgen USD 3.96B 464M Dec/2025
Bio Techne USD 54.46M 6.8M Dec/2025
Cassava Sciences USD -11.86M 2.23M Sep/2025
Cytokinetics USD -166.76M 55.25M Sep/2025
Esperion Therapeutics USD -16.03M 18.6M Sep/2024
Exelixis USD 235.91M 20.45M Dec/2025
Genmab DKK 360M 172M Jun/2025
Geron USD -13.89M 1.43M Sep/2025
Gilead Sciences USD 2.96B 551M Dec/2025
Incyte USD 383.88M 47.43M Dec/2025
MacroGenics USD 18.64M 55.4M Sep/2025
Novartis USD 4.5B 363M Sep/2025
Novavax USD -134.02M 296.12M Sep/2024